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Bioactive Molecules from Indian 
Medicinal Plants as Possible 
Candidates for the Management of 
Neurodegenerative Disorders
Uma Ranjan Lal and Snigdha Lal
Abstract
The present review gives an account of various bioactive molecules obtained 
from Indian medicinal plants for neurological degenerative disorders. Emphasis is 
laid on their correlation with the plants used in traditional system of medicine in 
India. The methodology involved in present review was enlisting of medicinal plants 
used for neurodegenerative disorders followed by their chemistry. A correlation with 
the chemical constituents and their recent findings has been done. Many medicinal 
plants such as Aloe vera and Bacopa monnieri have documented correlations and also 
need to be explored more. Molecules like garcinol (34), which was originally an anti-
cancer compound, have good correlation as neuroprotective agent. Likewise many 
plants that have not been explored but are used in traditional system of medicine 
have also been listed. Jaggery and honey, which are used in traditional formulations in 
large quantity, also have natural products that are used as neuroprotective agents. In 
conclusion, a lot more study is required to correlate the medicinal plants and herbal 
formulations to have much more natural products for neurodegenerative disorders.
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1. Introduction
Neurodegeneration is defined as a complex process that involves progres-
sive damage to the brain with neuronal loss leading to incurable and devitalizing 
consequences. The neurons, which get degenerated, are not restored, which result 
in impaired cognition and neurological disorders leading to depression, schizophre-
nia, Alzheimer’s disease, dementia, epilepsy, cerebral ischemia, and parkinsonism 
[1, 2]. These diseases involve various characteristic pathological and molecular 
features affecting neurons in various regions of the brain. Neurodegenerative 
diseases are accelerated by the way we live our daily lives. As per recent report by 
Indian Council of Medical Research (ICMR), the proportion of deaths estimated 
due to lifestyle diseases has increased from 37.09% in 1990 to 61.8% in 2016 [3]. 
Thus, there is an immense need for the development of strategies for its prevention 
as a number of patients suffering from lifestyle diseases are increasing day by day. 
Ayurveda is considered an old age traditional medicine of Indian practice involv-
ing considerable usage of plants and herbal preparations, which are known to cure 
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various disorders. Various classical formulations for neurodegenerative diseases are 
listed in Ayurvedic Formulary of India (AFI), which also provides a file of informa-
tion regarding single drugs of plant, animal, and mineral origin, providing their 
official names and English equivalents for their easy identification [4]. In present 
review, the major plants listed in the formulations indicated as neuroprotective is 
discussed. Present review outlines the chemical constituents and pharmacology of 
the listed plants. The sole aim of present review is to extract the hidden potential 
ancient formulations supported by modern findings so as to enhance their accept-
ability in masses. Further, a systematic approach for their chemical standardization 
is a need as it will be supportive in identifying therapeutic molecules, stating the 
need for combining scientific interpretations and traditional knowledge.
2. Indian medicinal plants and neurodegenerative diseases
The present sections describe plant material along with their chemical constitu-
ents and related pharmacology pertaining to neurodegenerative disorders. Few 
molecules with prominent activity have also been discussed.
3. Aloe vera (L.) Burm.f.
A. vera is a succulent, evergreen, perennial herb, which is being cultivated all over 
the world mainly for the purpose of agricultural and medicinal uses. Anthraquinones 
(aloe-emodin (1), chrysophanol (2), and a bitter reddish-yellow exudate containing 
majorly anthrones (aloin A and B (3)), aloe-emodin (4) [5], and few aloe resins such 
as aloeresin (5) and aloenin (6)) [6] are the major constituents in aloe (Figure 1). 
Aloe-emodin 4 is reported to enhance cognition against scopolamine-induced cogni-
tive impairment in mice [7]. Aloin 3 is shown to decrease intracellular ROS genera-
tion and reduced Ca2+ production, which is responsible for depolarization and death 
of the neuron, suggesting it as a useful and alternative therapy for cerebrovascular 
diseases [8]. A. vera gel demonstrated antioxidant and anti-inflammatory activities 
when given to the rats with sciatic nerve reperfusion injury [9].
Figure 1. 
Structures of compounds present in A. vera.
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4. Terminalia chebula Retz
Terminalia chebula (Combretaceae) commonly called Haritaki, is used in ayurvedic 
formulations, also reported to demonstrate neuroprotective activities. The principle 
constituents in pericarp of T. chebula fruits are phenolics (chebulic acid (7), chebulagic 
acid (8), chebulinic acid (9), ellagic acid (10), gallic acid (11)) [10] and triterpenoid 
glycosides chebuloside II (12) (Figure 2) [11]. Pericarp of fruits of T. chebula consti-
tutes Triphala (one of the popular formulations of ayurvedic system of medicine). 
The methanolic (70%) extract of the fruit Fructus chebulae has been shown to rescue 
cerebral ischemia by protecting neurons from degeneration. The in-vitro study and 
in-vivo studies have shown promising results [12]. Also, there is a promising decrease 
in the levels of malondialdehyde (MDA), NO, and microglial death stimulated by lipo-
polysaccharide (LPS) in the cells after treating with the extract [13]. The underlying 
mechanism might be the inhibition of inflammatory and oxidative processes. T. chebula 
constituents such as chebulagic acid, chebulinic acid, and ellagic acid have shown to be 
neuroprotective on various cell lines by showing its effect on various targets [14–16].
5. Honey and Jaggery
Both Honey and Jaggery are used in making of many ayurvedic preparations, and 
they constitute major part of many formulations [4]. Honey, a sweet and viscous 
substance, is produced by the honey bees (Apis spp.). It contains sugar and others 
such as minerals, proteins, essential oils, and flavonoids. Dietary polyphenols found 
in honey as well as other food and plant materials can prevent neurodegenerative 
disease in various ways [17–22]. These include oxidative protection of neurons [17], 
enhancement of neuronal function and regeneration [18], protection of neurons 
from Aβ-induced neuronal injury and neurotoxicity [19], protection of hippocampal 
cells against nitric oxide-induced toxicity [20], and modulation of neuronal and 
glial cell signaling pathways [21]. Luteolin (13) shows neuroprotective activity via 
prevention of microglia-associated inflammation in the hippocampus of aged rats 
[22]. Other flavonoids such as quercetin (14) and kaempferol (1) have also shown to 
be neuroprotective in various models. Kaempferol’s (15) neuroprotective effect was 
confirmed by the histochemical findings where it prevented the loss of TH-positive 
neurons induced by MPTP [23–25]. Luteolin 13, a flavone, has a significant role in 
treating CNS disorders through various mechanisms [26]. The activity of luteolin 13 
Figure 2. 
Structures of compounds present in T. chebula.
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Figure 3. 
Structures of compounds present in Jaggery and honey.
was also reported at its microglial transcriptome level for the treatment of CNS dis-
orders via anti-inflammatory activity [27]. Pretreatment of mice with luteolin 13 was 
expected to reduce the frequency of seizure in the PTZ mice model [28]. Luteolin 13 
also has the potential to improve the activity of oxygen-glucose deprivation/reperfu-
sion (OGD/R) induced neurons in a dose-dependent manner by enhancing the Na+/
K+-ATPase activity suggesting a potential molecule to treat cerebral ischemia [29]. 
Apigenin (16), a trihydroxyflavone, was reported to inhibit the release of glutamate 
from hippocampal nerve terminals, which might be useful in treating epilepsy [30]. 
The role of apigenin (16) in the treatment of cognition was demonstrated by attenu-
ating the Aβ-induced cytotoxicity in rat cortical neurons but having no intervention 
with oxidative stress. The biological activities of the flavonoids might be due to 
hydroxyl groups at R2 and R3 position influencing various cellular events eventually 
leading to apoptosis [27–30]. Other phenolics such as ferulic acid (17) exert neuro-
protective effect through middle cerebral artery occlusion [31] and by decreasing the 
number of microglia/macrophages after cerebral ischemia/reperfusion injury in rats 
[32]. Chlorogenic acid (18) present in honey exerts a neuroprotective effect against 
methyl mercury-induced apoptosis in pheochromocytoma-12 (PC12) cell lines. It 
prevents the generation of reactive-oxygen species (ROS), suppressing the decreas-
ing action of glutathione peroxidase (GPx) and GSH and attenuating apoptosis by 
the activation of caspase-3 [33] and also inhibits the activity of acetylcholine esterase 
and MDA in the hippocampus as well as in the frontal cortex in mice [34]. Honey as 
such has also shown to be neuroprotective in male Sprague-Dawley rats, and there 
was a decrease in the thiobarbituric acid reactive substance levels in the rats, which 
were pretreated with honey [35]. Chrysin (19) improved the morphological integrity 
of nigrostriatal neurons and increased the endogenous levels of BDNF, S100B, NGF, 
and GDNF in mice striatum improving behavioral and better muscular coordina-
tion [36]. Its lipophilic nature and bioflavonoid nucleus confers an added advantage 
to grow as a compelling therapeutic agent for neurological disorders. Pinocembrin 
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(20) elevated glutamate level, which was an important excitatory neurotransmitter 
produced by global cerebral I/R [37].
Jaggery is used in most of the ayurvedic formulations [4]. Traditionally, it is 
indicated for treating neurodegenerative disorders. The chemistry of sugar cane 
reveals that it is rich in phenolics and their glycosides [38], flavonoid glycosides, 
and flavones [39]. Tricin-7-glucoside (21) was reported to possess neuroprotective 
activity against cerebral ischemia via reduced expression of NF-κB and HMGB1. 
SH-SY5Y cells, which were pretreated with tricin (21a), reduced the apoptosis 
induced by OGD. Attenuation of histopathological damage reduced brain edema 
was reported in animal models of ischemia along with reduced NF-κB and HMGB1 
expression [40]. It also has potential for Alzheimer’s disease [41] (Figure 3).
6. Bacopa monnieri L.
Bacopa monnieri L. (Scrophulariaceae) is notable ayurvedic medicinal plant and 
referred to have impact on brain function and is a neural tonic to improve intel-
ligence and cognition [42]. Normal formulation Illumina® containing B. monnieri 
(leaf dry extract 43%, containing bacoside, 20%) decreased of 8-iso-PFG2α and 
ROS/RNS generation in the rat brain, consequently, decreasing the basal and H2O2 
and amyloid β peptide-incited oxidative stress [43]. In another study, standardized 
extract of B. monnieri (Bacoside A (22) content 82 ± 0.5%) when given in the doses 
of 5 and 10 mg/kg, orally, shows a dose-related increment in superoxide dismutase, 
catalase, glutathione peroxidase activities in the frontal cortex, striatum, and 
hippocampus [44]. B. monnieri, when administered orally, improves cognitive 
impairment and neurodegeneration in rats. Immunohistological recognition of 
superoxide dismutase (Cu/Zn-SOD) and histopathological changes in the CA1 
region of the hippocampus were observed [45]. An extract containing 5% (w/w) 
of the saponins, which contains bacoside A3, bacopasaponin X, bacopasaponin C 
(23), bacopaside II (24), and bacopaside I (25), shows improvements in cognitive 
abilities and neuroprotective impacts in Alzheimer’s disease model [46, 47]. When 
rats treated with bacoside A (22), huge changes were found in the degrees of both 
nonenzymatic and enzymatic antioxidants, which recommends that bacoside A 22 
improves B. monnieri antioxidant status in rat brain [48]. Other saponins such as 
(26-28) reported from this plant have been shown in Figure 4. A survey of 10 years 
of research at Swinburne University done by Con Stough et al. recommends that 
an extract of B. monnieri (CDRI 08: KeenMind) is a safe and effectual cognitive 
enhancer [49]. B. monnieri extract suppressed the generation of free radical levels 
and indicated critical assurance against 3-nitropropionic acid (3-NPA)-mediated 
cytotoxicity in dopaminergic (N27 cell lines) [50]. B. monnieri standard extract 
containing 55.34% of bacosides indicated a defensive impact on ischemia-induced 
memory hindrance and diminished the infarct size in the ischemic brain. It addi-
tionally demonstrated a critical increment in catalase action and exhaustion in lipid 
peroxidation, nitrite, and nitrate activity [51]. Neuronal cell cultures when treated 
with B. monnieri extract shielded neurons from β-amyloid-induced cell toxicity. 
The extract gave protection to cell cultures against glutamate-induced excitotoxic-
ity since it was not able to repress glutamate-mediated toxicity [52]. In Alzheimer’s 
disease animal model (C57/Bl6 mice), B. monnieri extract has decreased lipoxy-
genase action and hydrogen peroxide-induced lipid peroxidation. B. monnieri has 
neuroprotective mechanisms, and it lessens β-amyloid deposits in the brain of 
C57/Bl6 mice Alzheimer’s disease animal model [53]. B. monnieri extract have also 
shown to have protective effect against rotenone induced Parkinson’s disease in 
PC-12 cell lines [54].
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7. Asparagus racemosus Willd.
Methanolic extract of Asparagus racemosus decreased the degrees of cytokines, 
malondialdehyde (as a marker of lipid peroxides formation), and nitric oxide with 
a critical increment in the levels of catalase, superoxide dismutase, and glutathione, 
concluding its neuroprotective activity [55]. Its root extract (100 mg/kg) cured 
region-specific neurodegeneration created in Swiss albino mice [56] and also demon-
strated dose-dependent improvement in memory after histochemical and behavioral 
studies. A noteworthy decrease in transfer latency time and a significant increment 
in acetylcholinesterase (AchE) staining in histochemical identification were observed 
suggesting antioxidant, cholinergic, and neuroprotective properties of A. racemosus 
[57]. EuMil, a formulation containing standardized extracts A. racemosus Willd., has 
Figure 4. 
Structures of compounds present in B. monnieri.
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been used for stress-related problems and has been found to re-establish modified 
degree of nor-adrenaline, 5-hydroxytryptamine, and dopamine normal (100 mg/kg, 
p.o. 14 days) [58]. Withania somnifera and A. racemosus together have shown note-
worthy impacts in cell viability test, lactic dehydrogenase, malondialdehyde, gluta-
thione disulfide, glutathione, nerve growth factor, pro-brain-derived growth factor 
levels, and reactive oxygen species generation [59]. Ovariectomized adult female 
Wistar rats showed noteworthy upregulation of estrogen receptors (ERα and ERβ) in 
hippocampus and frontal cortex area alongside enhancement in the levels of brain-
derived neurotrophic factor. Upregulation of estrogen receptors and enhancement 
in the levels of brain-derived neurotrophic factor can be filled in as proof for neuro-
protective impact of ethanolic concentrate of A. racemosus roots [60, 61]. Significant 
protection is seen after the supplementation of Mentat (BR-16A) is an herbal psy-
chotropic preparation, containing A. racemosus against ethanol withdrawal-induced 
decrease of pentylenetetrazole threshold in rats and mice [62]. Sarsasapogenin, a 
steroidal saponin from A. racemosus, has been studied for neuroprotective impact in 
Alzheimer’s disease. Sarsasapogenin (29) indicated noteworthy restraint of butyryl-
cholinesterase, monoamine oxidase-B, beta-secretase 1, and acetylcholinesterase, key 
enzymes related to the pathogenesis of Alzheimer’s disease. At the point when tested 
against Aβ42 and H2O2-interceded cytotoxicity, sarsasapogenin showed a huge neu-
roprotective impact on PC12 cells. These discoveries recommended that sarsasapoge-
nin can go about as a multi-target directed ligand and as a reasonable lead compound 
for treating different elements engaged with the pathogenesis of Alzheimer’s disease 
[63]. Alterations in the normal levels of neurotransmitters, glutamate, acetylcho-
linesterase, dopamine, and protein because of worldwide cerebral ischemia were 
normalized by standardized A. racemosus Willd. root methanolic extract, appeared 
by the abatement in the degree of glutamate, acetylcholinesterase, and increment in 
dopamine levels and protein levels. Group treated with methanolic root extract of  
A. racemosus Willd. shown 85% neuronal protection in the CA1 area of the hippo-
campus. This demonstrated the cerebroprotective role of A. racemosus Willd. [64].
8. Foeniculum vulgare Mill.
Foeniculum vulgare extract reduced the amnesic effect and memory deficits in mice 
induced due to aging. F. vulgare extract demonstrated inhibition of acetylcholine, and 
in the exteroceptive behavioral model, it increased the step-down latency in mice sig-
nificantly [65]. Fennel essential oil inhalation inhibits beta-amyloid (1-42)-induced 
depression and anxiety and also indicates that it may have further clinical applica-
tions [66]. There were improvements in Parkinson’s disease in the animal model 
produced by F. vulgare Mill. essential oil [67]. Clinically fennel supplementation to 
obese middle-aged women decreased bodyweight, reduction in serum Aβ protein 
along with improvements in cognitive functions and metabolic profiling [68]. It 
normalized the expression levels of oxidative stress markers [Superoxide dismutase 
and Peroxiredoxin-6 (Prdx6)] and APP isoforms (APP common, 770 and 695) and 
also improved the Pb-induced morphological deterioration of cortical neurons [69].
9. Azadirachta indica A. Juss.
Commonly known as Neem in Indian subcontinent, Azadirachta indica has 
been shown to attenuate cisplatin-induced neurotoxicity in rats, and it also had 
neuroprotective effect on cerebral post-ischemic reperfusion and hypoperfusion 
[70, 71]. A. indica extracts have shown to be anti-oxidative and anti-apoptotic 
Natural Products - From Bioactive Molecules to Human Health
8
neuroprotective in Parkinson-induced functional damage [72]. A. indica standard-
ized leaf extract (total bitters 4.3%) has shown to be neuroprotective in partial 
sciatic nerve injury in rats as evidenced from anti-inflammatory, antioxidant, and 
anti-apoptotic studies [73].
10. Picrorhiza kurroa Royle ex Benth
Picrorhiza kurroa, an ayurvedic herb, has been shown to potentiate photochemo-
therapy in vitiligo [74]. Apocynin (30) from P. kurroa has shown to be neuroprotective 
in vivo [75]. It also shows protective effect in a mouse model of chemically induced coli-
tis [76]. It (4-hydroxy-3-methoxy-acetophenone, 30) mediates long-lasting memory 
recovery, helps in hippocampal neuroprotection, and reduces glial cell activation after 
transient global cerebral ischemia in rats [77]. Interestingly, the concentration of pic-
rosides I (31) and II (32) and apocynin 30 (iridoid rich fraction) in plasma (Cmax) was 
found to be 244.9, 104.6, and 502 ng/ml with half-life (t1/2) 14, 8, and 6 h, respectively 
[78]. P. kurroa also prevents memory deficits by inhibiting NLRP3 Inflammasome 
Activation and BACE1 Expression in 5xFAD Mice [79]. Acylated iridoid glycosides with 
hyaluronidase inhibitory activity from the rhizomes of P. kurroa Royle ex Benth have 
recently been isolated [80]. Therapeutic potentials of plant iridoids in Alzheimer’s and 
Parkinson’s diseases have separately been reviewed recently [81].
11. Berberine from Berberis aristata DC
Berberine (33) has been shown to be neuroprotective through the Nrf2 upregula-
tion and also alleviates rotenone-induced cytotoxicity by antioxidation and activa-
tion of PI3K/Akt signaling pathway in SH-SY5Y cells [82]. Neuroprotective effects 
of berberine have also been confirmed in animal models of Alzheimer’s disease 
[83]. Berberine nanoparticles have shown protective effect against LPS-induced 
neurodegenerative changes [84]. Berberine confers neuroprotection in coping with 
focal cerebral ischemia by targeting inflammatory cytokines[85]. Berberine had also 
shown protective effect against the altered intrinsic properties of the CA1 neurons 
induced by Aβ neurotoxicity [86]. There are many pathways by which berberine acts 
to protect neurons and has recently been reviewed. Authors have concluded that it 
being a potential candidate for combating neurodegenerative diseases [87, 88].
12. Garcinol from Garcinia indica Choisy
Garcinol (34) is one of the major constituents of Garcinia indica (a plant found 
in the region of Western Ghats of India). Garcinol can effectively restore the balance 
between the neurotransmitters glutamate and the γ-aminobutyric acid (GABA), rescue 
neural precursor cells, and promote their rapid growth. It regulates the expressions of 
glutamic acid decarboxylase 65 and GABAA receptors, preventing hyperactivation of 
NMDA receptor and the resultant excitotoxicity. It enhances memory and cognition in 
C57BL/6 mice, significantly lowering epileptic seizure scores [89, 90]. It also serves 
as a strong inhibitor of histone acetyltransferases (HAT), thus contributing protec-
tion against rapid neurodegeneration in parkinsonian brain [91, 92]. Garcinol helps 
in restoration of dopamine potency and has homocysteine lowering ability as well as 
have been shown to counter LDOPA-induced dyskinesia in PD model, demonstrate its 
worthiness as a potential drug candidate against Parkinson’s Disease [93, 94]. Garcinol 
also exhibits desirable anti-cholinesterase properties by inhibiting the enzyme acetyl 
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cholinesterase with an IC50 value of 0.66 μM, and it improves the neuronal count 
in hippocampal regions following administration of pentylenetetrazole (PTZ). In 
cultured rat cortical progenitor cells, garcinol can reduce cell death associated with 
growth factor deprivation. It also promotes neurite outgrowth in epidermal growth 
factor-responsive neural precursor cells and supports the survival of neurons [90]. 
In unilaterally 6-hydroxydopamine (6-OHDA)-lesioned hemi parkinsonian mice, 
5 mg/kg of garcinol co-treatment with L-DOPA effectively controlled the axial, 
limb, and orofacial (ALO) score for dyskinesia analysis. Following the administra-
tion of garcinol, a decreased expression of c-Fos, FRA-2, and ARC genes has been 
visualized [94], which is usually over-activated in L-DOPA induced dyskinesia [95]. 
Moreover, methanolic extract of G. indica, which is known to contain garcinol, 
effectively elevates dopamine level in the striatum and confers neuroprotection to 
dopaminergic neurons in 6-OHDA lesioned experimental rats [96]. Even pharmaco-
logical inhibition of HATs by garcinol can notably suppress MPP+-induced cell death 
due to reduction in ATP content [97]. In silico studies on the molecular interaction 
between garcinol and the active sites of COMT and MAO-B revealed that garcinol can 
potentially inhibit the activity of the two enzymes, similar to their known inhibitors 
[93]. In conclusion, garcinol may prove to be a dependable remedial measure in PD 
therapeutics since its inhibition of MAO-B and COMT can be correlated to increase 
the availability of dopamine as well as prevent the generation of toxic dopamine 
metabolites including homocysteine, 3-omethyldopa, 3-methoxytyramine, and 
3,4- dihydroxyphenylacetaldehyde [98] (Figure 5).
13. Nardostachys jatamansi (D. Don)DC.(Jatamansi)
The plant Nardostachys jatamansi is well exploited in Ayurvedic system of medi-
cine for its role in neurological disorders. Various phytochemicals have been reported 
from this plant by various authors. Its sedative and antidepressant activity, its 
mechanism (inhibition of MAO and GABA), and its role in rat cerebral ischemia have 
been documented [99]. Anticonvulsant activity and neurotoxicity profile of the plant 
have been generated [100]. The extracts of N. jatamansi have been found to attenu-
ate 6-hydroxydopamine-induced parkinsonism in rats, as proven by behavioral, 
Figure 5. 
Structures of compounds present in various plants for neuroprotective activity.
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neurochemical, and immunohistochemical studies [101]. It also improves learning 
and memory in mice. It also has stress modulating antioxidant effect. Its formula-
tion was also found to enhance the learning and memory process in rats [102–104]. 
It has shown neuroprotective efficacy in conjunction with selenium in cognitive 
impairment [105]. N. jatamansi root extract was found to modulate the growth of 
IMR-32 and SK-N-MC neuroblastoma cell lines through MYCN-mediated regula-
tion of MDM2 and p53 [106]. Novel Sesquiterpeniods and Anti-neuroinflammatory 
metabolites from N. jatamansi have also been isolated [107]. Compounds such as 
Desoxo-narchinol A 35 and Narchinol B 36 isolated from N. jatamansi have been 
shown to exert anti-neuroinflammatory effects by upregulating nuclear transcrip-
tion factor erythroid-2-related factor 2/heme oxygenase-1 signaling [108].
14. Other plants
Many plants, which have been used in traditional formulations for neurological 
disorders, need to be phytochemically explored and correlated with the modern 
findings. Table 1 gives the list of those plants with reported neuroprotective 
activity.
Plant name Part used Reports on neuroprotective activity Reference
Fumaria indica 
(Hausskn.) Pugsley
Leaf Significant activity of ethanolic extract on rat 
cognitive dysfunctions. Potential antianxiety 
activity of leaf extract; preclinical study
[109, 110]
Alhagi pseudalhagi 
(M. Bieb) Desv. ex 
B. Keller & Shap.
Whole 
plant
Traditionally used for neuroprotective disorders. 
Compounds having neuroprotective activity 
like flavanone glycosides and alkaloids like 
β-phenethylamine and tetrahydroisoquinoline have 
been reported
[111–114]
Pluchea lanceolata 
(Oliver & Hiern.)
Leaf Protection of hippocampal neurons from 
endothelin-1 induced ischemic injury to ameliorate 
cognitive deficits; protective effect against 
aluminum chloride-induced neurotoxicity in Swiss 
Albino mice; protective effect on LPS-induced 
neuro-inflammation in C6 rat glial cells
[115–117]
Premna mucronata 
Roxb.
Whole 
plant
Luteolin and apigenin are reported, and they are 
reported to be neuroprotective
[118]
Semecarpus 
anacardium L.f.
Fruits Stress induced neuroprotective activity [119]
Sida cordifolia L. Whole 
plant
Ameliorative effect in parkinsonism [120]
Tinospora cordifolia 
(Thunb.) Miers.
Stems Suppresses neuro-inflammation in Parkinsonian 
Mouse Model; potential neuro-regenerative 
candidate against glutamate induced excitotoxicity: 
an in vitro perspective
[121–123]
Trichosanthes dioica 
Roxb.
Rhizome Neuropharmacological properties of root [124]
Strobilianthes 
ciliatus (Nees.)
No such reports —
Table 1. 
List of plants whose exploration is required, as they are used tremendously in traditional system of medicine in 
India.
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15. Conclusions
In present review we focus on evidence to prevent neurodegenerative disorders 
in various studies (in vitro and in vivo). The mentioned medicinal plants play their 
protective roles via increased SOD and catalase levels, restoration of GSH, and 
decreased MDA levels and also protect neurons against ROS as antioxidant activi-
ties. The neuroprotective effects of the mentioned plants occur via reduction of 
inflammatory cytokines as well as enhancement of anti-inflammatory cytokines, 
inhibition of the acetylcholinesterase activity, and decreased MDA levels in the neu-
ral system via modulating GABAergic and glutamatergic neurons and also increas-
ing amount of amino acids and serotonin (5-HT) in the neurotransmitters systems. 
Based on the evidence produced, it is suggested that more exploration of traditional 
formulations is required, and also repurposing in natural products is also required 
to a greater extent, as is evident from recent reports on garcinol and berberine.
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